# Botulinum Toxin in the Treatment of Raynaud's

> **NCT01233999** · NA · COMPLETED · sponsor: **Emory University** · enrollment: 10 (actual)

## Conditions studied

- Raynaud's Syndrome

## Interventions

- **DRUG:** botulinum toxin A

## Key facts

- **NCT ID:** NCT01233999
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-10
- **Final completion:** 2012-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2014-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01233999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01233999, "Botulinum Toxin in the Treatment of Raynaud's". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT01233999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*